| Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2) | International journal of pharmaceutics |  | | 2010 | 688 | 0 |
|
| A high throughput protein formulation platform: case study of salmon calcitonin | Pharmaceutical research |  | | 2009 | 662 | 740 |
|
| Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity | Journal of Drug Targeting | | | 2009 | 424 | 1 |
|
| High throughput methods to characterize protein permeation and release | International journal of pharmaceutics | | | 2008 | 862 | 3 |
|
| Characterization of protein aggregation: the case of a therapeutic immunoglobulin | Biochimica et biophysica acta | | | 2007 | 649 | 0 |
|
| Detection and characterization of protein aggregates by fluorescence microscopy | International journal of pharmaceutics | | | 2007 | 655 | 0 |
|
| High throughput screening of protein formulation stability: practical considerations | European journal of pharmaceutics and biopharmaceutics | | | 2007 | 661 | 0 |
|
| Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates | European journal of pharmaceutics and biopharmaceutics | | | 2006 | 389 | 1 |
|
| Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity | Vaccine | | | 2005 | 47 | 0 |
|
